Putting artificial intelligence at the heart of health care — with help from MIT
Cardiologist Demilade Adedinsewo is using her MIT Professional Education experience to advance cardiovascular care at the Mayo Clinic.
Cardiologist Demilade Adedinsewo is using her MIT Professional Education experience to advance cardiovascular care at the Mayo Clinic.
Scientists employ an underused resource — radiology reports that accompany medical images — to improve the interpretive abilities of machine learning algorithms.
Neural network identifies synergistic drug blends for treating viruses like SARS-CoV-2.
Neuroscientists at MIT and Massachusetts General Hospital develop a statistical framework that describes brain-state changes patients experience under ketamine-induced anesthesia.
The PhD student uses machine learning as a tool for studying pain and consciousness — and as subject matter for her popular videos.
Entrepreneurship class MAS.664 launches businesses with a global reach.
MIT researchers employ machine learning to find powerful peptides that could improve a gene therapy drug for Duchenne muscular dystrophy.
Diagnostic nanoparticles could be used to monitor tumor recurrence after treatment or to perform routine cancer screenings.
The sensor technology could also be used to create clothing that detects a variety of pathogens and other threats.
Former naval petty officer Manuel Morales now develops imaging applications to detect cardiac dysfunction in young patients.
MIT instructors honored for creating multidimensional, multidisciplinary online courses that help learners everywhere address real-world problems.
Nearly 1,400 joined the AI for Health Care Equity Conference that explored new AI technologies as a platform for change.
A machine learning model developed jointly by Janssen and MIT data scientists played a key role in the clinical trial process for the Johnson & Johnson Covid-19 vaccine.
Alumni-founded Multiply Labs uses an automated manufacturing platform to produce advanced treatments at scale.
Kytopen is speeding up both discovery and delivery of engineered cell therapies with its transformative Flowfect platforms.